Once the disposition of low doses of a compound is established, the effect of increasing dose on distribution patterns and excretion routes needs to be determined. Of particular interest is the saturation of metabolic pathways leading to a nonlinear relationship between the level of exposure and the dose to the target tissue. Doses that are lower than those exceeding the total metabolic capacity of the host might still be high enough to cause shifts in metabolic pathways from low capacity and high affinity enzymes to high capacity and low affinity enzymes. Such shifts might greatly influence the toxic effects exerted by the compound, depending on the kinetic characteristics of the pathway leading to formation of the toxic metabolite. Information on the disposition of a compound as a function of dose is essential for evaluating risks to humans exposed at low doses on the basis of the results of animal toxicity studies conducted at high doses.
The effect of repeated dosing on the distribution, metabolism, and excretion of the compound needs to be determined to evaluate the risks of individuals subject to multiple exposures over time properly. These studies are necessary to take into account the possibility of the induction of enzymes to either increase or decrease the level of toxic metabolites. Other dose-rate effects such as accumulation of lipid-soluble metabolites in fatty tissues can also be evaluated in repeated dosing studies.
Basic pharmacokinetic studies, which are generally conducted in animal models, need to be done with careful attention to mass balance. When studying the disposition of a pesticide, all of the material that entered the animal needs to be accounted for, either by retention in tissues or by excretion. Thus, all tissues and excreta should be analyzed for the presence of the administered compound or its metabolites. Whole-body radiography can be used to detect small amounts of radiolabeled material in small organs that might not always be analyzed.
A major point of discussion was the consensus tier approach to pharmacokinetic studies developed by the Synthetic Organic Chemical Manufacturers Association's Pharmacokinetics Group and presented by Alan Wilson. There was some concern about putting off identification of metabolites until tier three, although others stated that it was logical to determine whether metabolism of the substance occurs before attempting to determine the identity of metabolites. In general, the tier approach was considered appropriate as long as it is implemented with sufficient flexibility to take into account different informational needs for different materials.
When Should Pharmacokinetic Data Be Obtained in Toxicity Testing?
Two approaches for using pharmacokinetic data were discussed. One approach was using pharmacokinetic data for study design; the other was using such data for interpretation of already completed studies. The advantage of doing pharmacokinetic studies early (say in parallel with shortterm toxicity studies) is that the effects of dose on the uptake and metabolism of the compound of interest will be known before setting exposure levels for long-term studies. Also, secondary mechanisms such as those described by Eldridge can be detected in time to avoid the use of an inappropriate animal model in long-term studies. For example, if pharmacokinetic studies indicated that a shift in metabolism resulting in a marked increase in the formation of toxic compound occurred at higher doses, it would be desirable to include an appropriate number of animals below that saturation point in long-term studies. If pharmacokinetic data in inhalation studies indicated that the dose to the target tissue did not increase because of a decrease in respiration rate or absorption above a certain exposure concentration, higher exposure concentrations would not be needed in the long-term studies.
The discussants who favored doi-ng pharmacokinetic studies to aid in interpre- Mathematical models were considered by panelists to be a powerful tool for application of pharmacokinetic data. Models describing the pharmacokinetics of chemicals can be developed in animals and, with appropriate scaling techniques, can be used to predict the pharmacokinetic behavior of the same compound in humans. Biologically based models, which include appropriate physiological, biochemical, and metabolic parameters, provide a useful framework for describing the kinetics of distribution of a compound or its metabolites in the body. Such physiologically based pharmacokinetic models sometimes are most useful when the data do not fit the model. In this case, the investigator must try to determine what is missing from the model and develop a modified model that adequately describes the data. The exercise of model building and model refinement often provides useful insight into pharmacokinetic processes involved in the handling of xenobiotics by the body. In the work by Gearhart et al., the modeling process was carried one step further by melding the modeling of pharmacokinetic and pharmacodynamic data. They indicated that such an integrated biologically based modeling approach can provide a more complete description of the sequence of events leading to a toxic response to pesticide exposure. The panelists discussed the differences between children and adults in exposure to pesticides and in the rate of metabolism or clearance of the compound. Children are exposed to different amounts of pesticides by ingestion than are older persons. Studies at the University of Pittsburgh indicate that human breast milk is more contaminated with pesticides than cow's milk, although the degree of contamination of breast milk has gone down since 1986 (1). On a body weight basis, children are known to eat or drink more of certain foods or beverages such as apple juice than adults do (Figure 1) . Therefore, in determining the potential dosimetry of children to pesticide-contaminated food, the increased intake of certain food products in children must be considered.
Information from studies on blood levels of administered cancer chemotherapeu- Environmental Health Perspectives and the Occupational Safety and Health Administration, who reported that the ratio of liver to body weight is high in children. Thus, children may clear some chemicals faster than adults because clearance of some drugs is dependent on total liver mass.
Another factor that must be taken into account is the nutritional status of exposed people. It is well known that undernourished children or elderly persons have a decreased ability to mount and maintain normal immune response and thus they respond poorly to vaccination procedures that are effective in well-nourished children. Undernourished people also have less defense against toxic materials than wellnourished individuals because of decreased host defense mechanisms.
